These findings underscore the complex regulation of peroxisome abundance in PCa, suggesting that factors such as PEX10 and MCT2 may play a role in modulating peroxisome dynamics and could contribute to the development of new therapeutic strategies. This evidence concerns the gene SLC16A7 and posterior cortical atrophy.